抗MDA5皮肌炎的免疫失调与感染易感性
本综述综合队列数据表明,抗MDA5皮肌炎患者较其他炎性肌病感染负担显著增加,尤其是肺孢子菌肺炎和巨细胞病毒感染,诊断后早期事件聚集且短期死亡率明显升高。机制涉及持续I/III型干扰素信号、中性粒细胞胞外诱捕网异常、淋巴细胞及NK细胞耗竭和抗体介导的血管损伤。作者主张对高危表型行常规PJP预防和病毒再激活监测,并制定疾病特异性方案。
要点
- 抗MDA5皮肌炎患者感染风险显著高于其他炎性肌病,以PJP和CMV为突出。
- 诊断后早期感染事件聚集,短期死亡率明显增加。
- 推荐高危表型常规PJP预防并监测病毒再激活。
核心结论
- 抗MDA5皮肌炎患者感染负担过重,需疾病特异性筛查、预防和监测方案以降低感染相关死亡。
研究设计与样本
- 本综述综合成人及儿科队列数据,总结抗MDA5皮肌炎的感染风险及转化研究证据。
主要发现
- 抗MDA5皮肌炎患者病毒感染、细菌感染和真菌感染发生率均高于其他炎性肌病。
- 肺孢子菌肺炎(PJP)和巨细胞病毒感染负担尤为突出。
- 诊断后感染事件早期聚集,短期死亡率明显升高。
- 持续I/III型干扰素信号、中性粒细胞胞外诱捕网异常、淋巴细胞及自然杀伤细胞耗竭和抗体介导血管损伤可能共同损害皮肤和肺屏障防御。
- 上述机制也可能参与自发性纵隔气肿等并发症。
关键数值与推荐
- 当前筛查、疫苗接种和抗微生物预防建议多从其他自身免疫病外推,可能低估抗MDA5皮肌炎患者风险。
- 作者主张对高危表型行常规PJP预防并监测病毒再激活。
临床怎么用
- 对高危抗MDA5皮肌炎表型应考虑常规PJP预防。
- 应监测病毒再激活,尤其巨细胞病毒。
- 现有外推建议可能低估风险,需疾病特异性方案。
局限性
- 当前建议多从其他自身免疫病外推,缺乏抗MDA5皮肌炎特异性证据。
- 需前瞻性和机制研究以降低感染相关发病率和死亡率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antibodies targeting melanoma differentiation-associated gene 5 protein (MDA5) are associated with a distinct subtype of dermatomyositis characterised by cutaneous ulceration, systemic inflammation, and a high risk of rapidly progressive lung disease. Beyond these manifestations, patients experience disproportionately high rates of infection compared with other inflammatory myopathies, including viral, bacterial, and fungal complications. This review synthesises cohort data demonstrating an excess burden of infections, particularly Pneumocystis jirovecii pneumonia (PJP) and cytomegalovirus, attributed to both disease-specific factors and immunosuppression. We summarise adult and paediatric cohorts in which anti-MDA5 dermatomyositis confers a higher risk of serious and opportunistic infection, early clustering of events after diagnosis, and markedly increased short-term mortality. Emerging translational evidence suggests that persistent type I and III interferon signalling, abnormal neutrophil extracellular trap formation, lymphocyte and natural killer cell depletion, and antibody-mediated vascular injury may converge to impair host defence at cutaneous and pulmonary barriers, and may also contribute to complications such as spontaneous pneumomediastinum. Current recommendations for screening, vaccination, and antimicrobial prophylaxis are largely extrapolated from other autoimmune diseases and may underestimate risk in patients with anti-MDA5 dermatomyositis. On the basis of available data, we argue that disease-specific protocols, including routine PJP prophylaxis in high-risk phenotypes and surveillance for viral reactivation, are warranted, and we outline key priorities for prospective and mechanistic studies aimed at reducing infection-related morbidity and mortality in this high-risk subgroup.
引用
- Moore KE, Khoo T, Limaye V, et al. Immune dysregulation and infection susceptibility in Anti-MDA5 dermatomyositis. Semin Arthritis Rheum. 2026. PMID: 41812320. doi:10.1016/j.semarthrit.2026.152967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。